FUSION POLYPEPTIDE INHIBITING VEGF-C, VEGF-D AND/OR ANGIOPOIETIN-2, AND USE THEREOF

摘要

The purpose of the present invention is to provide a fusion polypeptide which can inhibit proliferation and transition of cancer cells, and formation of a lymphatic vessel. The present invention relates to a fusion polypeptide which can be combined to angiopoietin 2, VEGF-C, and VEGF-D at the same time, and to preparation thereof and uses. Also, the present invention relates to a fusion polypeptide which can be combined to VEGF-C and VEGF-D at the same time, and to preparation thereof and uses.